24-25 Octobre 2024
Washington DC, Etats-Unis<\/p>\n\n\n\n
Â鶹Æƽâ°æ participe \u00e0 l’\u00e9v\u00e8nement MOSAIC – Global NASH Trialist Forum 2024. Ce forum avait pour objectif de d\u00e9finir une nouvelle approche clinique int\u00e9grant les volets Cardiovasculaire-R\u00e9nal-H\u00e9patique-M\u00e9tabolique pour de futurs essais cliniques, regroupant des cliniciens sp\u00e9cialis\u00e9s dans les essais cliniques en cardiologie, endocrinologie et h\u00e9patologie ainsi que des experts industriels, en r\u00e9gulatoire et repr\u00e9sentants de patients.<\/p>\n\n\nhttps:\/\/mosaic-nash.tmacademy.org\/<\/a>","protected":false},"excerpt":{"rendered":" 24-25 Octobre 2024 Â鶹Æƽâ°æ participe \u00e0 l’\u00e9v\u00e8nement MOSAIC – Global NASH Trialist Forum 2024. Ce forum avait pour objectif de d\u00e9finir une nouvelle approche clinique int\u00e9grant les volets Cardiovasculaire-R\u00e9nal-H\u00e9patique-M\u00e9tabolique pour de futurs essais cliniques, regroupant des cliniciens sp\u00e9cialis\u00e9s dans les essais cliniques en cardiologie, endocrinologie et h\u00e9patologie ainsi que des experts industriels, en r\u00e9gulatoire et repr\u00e9sentants de patients.<\/p>\n https:\/\/mosaic-nash.tmacademy.org\/<\/a>Lire la suite »<\/a><\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-5769","post","type-post","status-publish","format-standard","hentry","category-events-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"adm-cdubreuil","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/adm-cdubreuil\/"},"rttpg_comment":0,"rttpg_category":"\u00c9v\u00e9nements<\/a>","rttpg_excerpt":"24-25 Octobre 2024Washington DC, Etats-Unis Â鶹Æƽâ°æ participe \u00e0 l’\u00e9v\u00e8nement MOSAIC – Global NASH Trialist Forum 2024. Ce forum avait pour objectif de d\u00e9finir une nouvelle approche clinique int\u00e9grant les volets Cardiovasculaire-R\u00e9nal-H\u00e9patique-M\u00e9tabolique pour de futurs essais cliniques, regroupant des cliniciens sp\u00e9cialis\u00e9s dans les essais cliniques en cardiologie, endocrinologie et h\u00e9patologie ainsi que des experts industriels,…","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/5769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=5769"}],"version-history":[{"count":11,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/5769\/revisions"}],"predecessor-version":[{"id":5784,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/5769\/revisions\/5784"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=5769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=5769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=5769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Washington DC, Etats-Unis<\/p>\n